ZA87255B - Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension - Google Patents

Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension

Info

Publication number
ZA87255B
ZA87255B ZA87255A ZA87255A ZA87255B ZA 87255 B ZA87255 B ZA 87255B ZA 87255 A ZA87255 A ZA 87255A ZA 87255 A ZA87255 A ZA 87255A ZA 87255 B ZA87255 B ZA 87255B
Authority
ZA
South Africa
Prior art keywords
hydrogel
suspension
obtaining
pharmaceutical preparation
highly viscose
Prior art date
Application number
ZA87255A
Other languages
English (en)
Inventor
Bobby Liep Siang Kwee
Johannes Gerhardus Jo Egberink
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA87255B publication Critical patent/ZA87255B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA87255A 1986-01-24 1987-01-14 Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension ZA87255B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8600155 1986-01-24

Publications (1)

Publication Number Publication Date
ZA87255B true ZA87255B (en) 1987-08-26

Family

ID=19847460

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87255A ZA87255B (en) 1986-01-24 1987-01-14 Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension

Country Status (15)

Country Link
US (1) US4818517A (xx)
EP (1) EP0231040B1 (xx)
JP (1) JPH0764720B2 (xx)
KR (1) KR940011241B1 (xx)
AT (1) ATE62412T1 (xx)
AU (1) AU597330B2 (xx)
CA (1) CA1287580C (xx)
DE (1) DE3769160D1 (xx)
DK (1) DK30187A (xx)
ES (1) ES2035847T3 (xx)
GR (1) GR3002269T3 (xx)
IE (1) IE59361B1 (xx)
NZ (1) NZ218948A (xx)
PT (1) PT84188B (xx)
ZA (1) ZA87255B (xx)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225192A (en) * 1988-10-17 1993-07-06 Vectorpharma International S.P.A. Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
DE3775054D1 (de) * 1987-06-16 1992-01-16 Akzo Nv Zweikammer-spritze und herstellungsverfahren.
EP0794795A1 (en) * 1994-03-24 1997-09-17 Boehringer Ingelheim Agrovet A/S Dispensing unit containing a particulate product for the administration of drugs or nutrient preparations to animals and process for the manufacture of the particulate product
SE9602644D0 (sv) * 1996-07-04 1996-07-04 Astra Ab New use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
JP2001509480A (ja) 1997-07-09 2001-07-24 アンドロソリューションズ，インク． 男性勃起機能不全を治療するための改良された方法及び組成物
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US6593369B2 (en) 1997-10-20 2003-07-15 Vivus, Inc. Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US20050070516A1 (en) * 1997-10-28 2005-03-31 Vivus Inc. As-needed administration of an androgenic agent to enhance female desire and responsiveness
JP2001520999A (ja) 1997-10-28 2001-11-06 アシビ， エルエルシー 女性の性的機能不全の処置
US5877216A (en) * 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
AU1339501A (en) * 1999-10-22 2001-05-08 Antares Pharma, Inc. Medicament cartridge and injection device
US6264987B1 (en) * 2000-05-19 2001-07-24 Alkermes Controlled Therapeutics Inc. Ii Method for preparing microparticles having a selected polymer molecular weight
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
US6471995B1 (en) * 2000-09-27 2002-10-29 Alkermes Controlled Therapeutics, Inc. Ii Apparatus and method for preparing microparticles using liquid-liquid extraction
US20020114843A1 (en) * 2000-12-27 2002-08-22 Ramstack J. Michael Preparation of microparticles having improved flowability
MXPA04006875A (es) * 2002-01-18 2004-12-06 Control Delivery Sys Inc Sistema de gel polimerico para suministro controlado de cofarmacos.
KR20040103930A (ko) 2002-02-11 2004-12-09 앤태어스 파머, 인코퍼레이티드 피내 주사기
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
US6841574B2 (en) * 2003-01-03 2005-01-11 Nexmed Holdings, Inc. Topical stabilized prostaglandin E compound dosage forms
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US8617613B2 (en) 2004-04-15 2013-12-31 Alkermes Pharma Ireland Limited Polymer-based sustained release device
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US7080755B2 (en) 2004-09-13 2006-07-25 Michael Handfield Smart tray for dispensing medicaments
ES2716135T5 (es) 2005-01-24 2023-06-15 Antares Pharma Inc Inyector de chorro asistido por aguja con jeringa precargada
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8251947B2 (en) 2006-05-03 2012-08-28 Antares Pharma, Inc. Two-stage reconstituting injector
WO2007137839A2 (en) * 2006-05-31 2007-12-06 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
TWI436793B (zh) * 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
WO2008092068A2 (en) * 2007-01-25 2008-07-31 Hyperbranch Medical Technology, Inc. Applicators for multiple component formulations and the like, and methods of use thereof
AU2008231093A1 (en) * 2007-03-22 2008-10-02 Alkermes, Inc. Coacervation process
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
US20080317865A1 (en) * 2007-06-20 2008-12-25 Alkermes, Inc. Quench liquids and washing systems for production of microparticles
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP2259803B2 (en) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
ES2738539T3 (es) 2008-08-05 2020-01-23 Antares Pharma Inc Inyector de dosis múltiples
JP5732039B2 (ja) 2009-03-20 2015-06-10 アンタレス・ファーマ・インコーポレーテッド 危険有害性薬剤の注入システム
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
MX2011013795A (es) * 2009-06-16 2012-04-30 Baxter Int Esponja hemostatica.
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
EP2512535A1 (en) * 2009-12-16 2012-10-24 Baxter International Inc Hemostatic sponge
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
IT1400323B1 (it) * 2010-05-07 2013-05-24 Univ Degli Studi Torino Metodo per il rilascio controllato di un principio attivo
AU2011260274B2 (en) 2010-06-01 2015-07-02 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
MX345479B (es) 2010-06-01 2017-02-01 Baxter Int Inc * Proceso para elaborar composiciones hemostaticas secas y estables.
CN103037847B (zh) 2010-06-01 2016-01-20 巴克斯特国际公司 用于制备干燥、稳定的止血组合物的方法
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US8496619B2 (en) 2011-07-15 2013-07-30 Antares Pharma, Inc. Injection device with cammed ram assembly
US9220660B2 (en) 2011-07-15 2015-12-29 Antares Pharma, Inc. Liquid-transfer adapter beveled spike
JP6195569B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
WO2013053755A2 (en) 2011-10-11 2013-04-18 Baxter International Inc. Hemostatic compositions
UY34414A (es) 2011-10-27 2013-04-30 Baxter Int Composiciones hemostáticas
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
JP6457383B2 (ja) 2012-04-06 2019-01-23 アンタレス・ファーマ・インコーポレーテッド テストステロン組成物の針支援式ジェット注入投与
WO2013169800A1 (en) 2012-05-07 2013-11-14 Antares Pharma, Inc. Injection device with cammed ram assembly
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
EP4349383A3 (en) 2013-02-11 2024-06-19 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force
CA2905031C (en) 2013-03-11 2018-01-23 Hans PFLAUMER Dosage injector with pinion system
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
WO2016102446A1 (en) 2014-12-24 2016-06-30 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2017007515A1 (en) * 2015-07-09 2017-01-12 Universal Nutrients, Llc Pharmaceutical compositions
TWI814219B (zh) 2016-05-16 2023-09-01 美商因塔希亞治療公司 升糖素受體選擇性多肽和彼之使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
SE431821B (sv) 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
US4693887A (en) * 1983-09-15 1987-09-15 The Kendall Company Microphase separated hydrogels for controlled release of bioactive materials
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物

Also Published As

Publication number Publication date
US4818517A (en) 1989-04-04
KR870006893A (ko) 1987-08-13
AU6786187A (en) 1987-07-30
JPH0764720B2 (ja) 1995-07-12
ATE62412T1 (de) 1991-04-15
DE3769160D1 (de) 1991-05-16
EP0231040B1 (en) 1991-04-10
GR3002269T3 (en) 1992-12-30
DK30187A (da) 1987-07-25
DK30187D0 (da) 1987-01-20
PT84188B (pt) 1989-03-30
EP0231040A1 (en) 1987-08-05
AU597330B2 (en) 1990-05-31
IE870071L (en) 1987-07-24
KR940011241B1 (ko) 1994-12-03
IE59361B1 (en) 1994-02-09
JPS62190119A (ja) 1987-08-20
CA1287580C (en) 1991-08-13
PT84188A (pt) 1987-02-01
NZ218948A (en) 1989-04-26
ES2035847T3 (es) 1993-05-01

Similar Documents

Publication Publication Date Title
ZA87255B (en) Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension
IT1170375B (it) Apparecchio che infonde insulina o glucosio nel soggetto diabetico sulla base di determinazioni di concentrazioni di glucosio ottenute senza bisogno di prelievi del sangue del paziente
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
FI863990A (fi) Farmaseuttisen tai diagnostisen aineen oftalmologinen kantoainekoostumus
DE69523733D1 (de) Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten
DE3578647D1 (de) Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
ES2075468T3 (es) Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.
SE8900586L (sv) Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
ES2007607A6 (es) Un procedimiento para la obtencion de un preparado de insulina para la administracion no parenteral.
ES414976A1 (es) Perfeccionamientos en aparatos de injertos de dentaduras postizas.
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
GR3003805T3 (xx)
ATE3814T1 (de) Verfahren zur herstellung eines festen formkoerpers mit einem gehalt an einem arzneimittelwirkstoff oder einem diagnostikum.
SE8601563D0 (sv) Matrismaterial, forfarande for framstellning derav och anvendning derav
ATE84228T1 (de) Spritze.
RU96106336A (ru) Способ введения лекарственных средств в полость сустава
SE9901257D0 (sv) Behandling av smärta efter ledoperation
GB1317858A (en) Process for producing articles from hydrophilic polymers appropriate for repeated or long-term-contact with living tissue or mucous membrane
SU1702412A1 (ru) Способ моделировани недостаточности трипсина IN VIVo
SU1273051A1 (ru) Способ эндолимфатического введени лекарственных и диагностических средств
RU93055556A (ru) Препарат для лечения мастита крупного рогатого скота "лизомаст"
JPS57200316A (en) Examination of pancreatic exocrine function
DE3176479D1 (en) Composition for increasing blood pressure
SU936512A1 (ru) Способ предотвращения свертывания крови